Skip to main content
editorial
. 2019 May 16;8(2):215–230. doi: 10.1007/s40120-019-0138-z

Table 2.

Summary of lurasidone’s pharmacokinetic profile [12, 13]

Pharmacokinetic property Details
Absorption
 Bioavailability 9–19%
 Time to peak plasma concentration 1–3 h
 Time to reach steady state 7 days
Distribution
 Protein binding (serum proteins) ~ 99%
Metabolism
 Route Hepatic; CYP3A4-mediated
Elimination
 Route Faeces (80%); urine (9%)
 Elimination half-life 20–40 h

CYP Cytochrome P450